Health News

WASHINGTON (MedPage Today) — Makers of the supplement ArimaDex — advertised to boost testosterone and build lean muscle mass — voluntarily recalled the product after traces of an aromatase inhibitor used in the treatment of breast cancer was found in an FDA analysis.

Read more

Filed under: General Health News
Tags: Breast Cancer, cancer, Drug, General Health News, muscle

Related posts

• Vitamin D Relieves Joint, Muscle Pain For Breast Cancer Patients (0)
  High-dose vitamin D relieves joint and muscle pain for many breast cancer patients taking estrogen-lowering drugs, according to a new study from Washington University School of Medicine in St. Louis. The drugs, known as aromatase inhibitors, are commonly prescribed to shrink breast tumors fueled by the hormone estrogen and help prevent cancer recurrence... Read more [tags] Women's [...]
  
  
• Traces of CA Drug Prompts Muscle Builder Recall (0)
  WASHINGTON (MedPage Today) -- Makers of the supplement ArimaDex -- advertised to boost testosterone and build lean muscle mass — voluntarily recalled the product after traces of an aromatase inhibitor used in the treatment of breast cancer was found in an FDA analysis. Read more [tags] Pharmacy News [/tags]
  
  
• Study identifies causes of bone loss in breast cancer survivors (0)
  (Loyola University Health System) Osteoporosis is a growing concern among breast cancer survivors and their doctors because certain cancer drugs can cause bone loss. But a new study has found that cancer drugs aren't the only culprits. Among 64 breast cancer patients referred to a bone health clinic, 78 percent had at least one other [...]
  
  
• Researchers identify new protein that triggers breast cancer (0)
  (University of Montreal) Canadian researchers have identified a new protein in the progression of breast cancer. According to a recent study from the Universite de Montreal and the University of Alberta, published in the Journal of Biological Chemistry, the protein ARF1 plays a critical role in cancer cell growth and the spread of tumors. Targeting [...]
  
  
• New Bevacizumab Data Fails to Support Use in Advanced Breast CA (0)
  WASHINGTON (MedPage Today) -- Adding bevacizumab (Avastin) to chemotherapy drugs doesn't increase survival or improve symptoms for women with advanced breast cancer, according to FDA documents posted in advance of an advisory panel meeting on Tuesday. Read more [tags] General Health News [/tags]